News / Korea / yonhap_finance
Skylabs Soars 135% on KOSDAQ Debut
Health Technology · Medical Specialties · yonhap_finance · 2026-09-04
386380
Medical device manufacturer Skylabs closed its first day of trading on the KOSDAQ up 135% from its IPO price, marking a successful market entry.
What Happened
Market Debut: Medical device maker Skylabs made a strong debut on the KOSDAQ, closing at 23,500 KRW, up 135% from its IPO price of 10,000 KRW. Despite an early dip of 18%, the stock rebounded sharply, reaching an intraday high of 187% before settling.
Company Profile: Founded in 2015, Skylabs specializes in cuffless continuous blood pressure monitoring devices. The company's IPO was managed by Korea Investment & Securities.
Financials: The company reported 7.9 billion KRW in revenue and an operating loss of 14.7 billion KRW for the previous year. The IPO attracted institutional interest with a subscription ratio of 63.41 to 1.
Outlook: Following a successful first day, the company now faces the challenge of proving its technological edge and improving profitability in the competitive medical device market. Investors will be closely watching its future financial performance.